Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCENT: N-Acetylcysteine for Cannabis Cessation
NCT01675661Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Jan 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01675661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675661.